Serial Number | 97433162 |
Word Mark | REVEAL BIOSCIENCES |
Filing Date | Friday, May 27, 2022 |
Status | 653 - SUSPENSION LETTER - MAILED |
Status Date | Wednesday, December 13, 2023 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | NOT AVAILABLE |
Goods and Services | Downloadable software for human and animal tissue processing and analysis; Downloadable software for image processing and analysis; Downloadable software for producing quantitative Nonalcoholic fatty liver disease (NAFLD) activity scoring and quantitative fibrosis scoring; Downloadable electronic data files featuring pathology, microscopy, and histology images and data; Downloadable electronic data files featuring images and data for use in preclinical research, clinical trials, and decision support; Downloadable files containing digital assays; Downloadable image files containing biological tissue samples and medical tissue samples; Downloadable images in the field of pathology, histology, immunohistochemistry, immunofluorescence, and in situ-hybridization; Downloadable scientific and medical data via the internet; Specimen collection kits, comprised of specimen containers, vials, caps, and microscope slides; Specimen collection kits for clinical trial research, comprised of specimen containers, vials, caps, and microscope slides; plastic and glass tubes and vials for research sample collection and storage; laboratory equipment, namely, microscope slides; wipes and swabs for use in collecting samples for laboratory and clinical trial research; Testing sample collection equipment, namely, wipes, swabs, tubes, vials, and for use in experimental testing, not for medical purposes |
Goods and Services | Clinical pathology services; clinical histology services; consulting services in the field of pathology and histology; medical consultations; consulting services provided by specialized medical personnel, namely, veterinary and anatomic pathologists; medical imaging services; clinical medical services in the field of pathology, histology, immunohistochemistry, immunofluorescence, and in situ hybridization |
Goods and Services | Scientific research and development; Medical research and development; Product research and development; Biochemical research and development; Pharmaceutical research and development services; Biomedical research and development services; Design and development of biochemical, pharmaceutical, and medical assays; Scientific and pharmaceutical research in the field of biomarker discovery; Conducting clinical trials for others; Conducting clinical trials for others in the fields of pharmaceutical, medical, and scientific research; Consulting services for others in the field of design, planning, and implementation project management of clinical trials; Conducting research and clinical trials for others in the fields of oncology, infectious diseases, autoimmune disorders, and allergies; Consulting services in the field of clinical trial research; Providing medical and scientific research information in the field of clinical trials; Research and development in the pharmaceutical and biotechnology fields; Laboratory research services relating to pharmaceuticals; Research services in the field of pathology; Software as a Service (SaaS) service for human and animal tissue processing; Software as a Service (SaaS) services for storing slide images and image management; Software as a Service (SaaS) for slide scanning and imaging instruments; Software as a service (SAAS) services featuring software for managing, processing and analyzing pathology, microscopy, and histology data; Software as a service (SAAS) services featuring software for use in the medical imaging field, namely, pathology, microscopy, and histology, for performing digital image management; Software as a service (SAAS) services featuring software for use in the medical imaging field, namely, pathology, microscopy, and histology for enabling remote or local viewing, annotating, and analysis of digital images; Software as a service (SAAS) services featuring software for image management and analysis; Software as a service (SAAS) services featuring software for use in the electronic storage of data, images and files; Software as a service (SAAS) services featuring software for managing, reviewing and analyzing digital assays; Software as a service (SAAS) services featuring software for processing medical images; Software as a service (SAAS) services featuring software for use in the diagnosis of diseases, states, or conditions; Software as a service (SAAS) services featuring software for artificial intelligence, machine learning, deep learning, statistical learning, data mining, and contextual prediction; Software as a service (SAAS) services featuring software using artificial intelligence for processing and analyzing medical images; Providing a web site featuring technology that enables users to find and match with appropriate pathology professionals; Providing a web site featuring technology that enables users to interact with and exchange data, images and files with pathology professionals; Scientific and technological services, namely, scientific research, analysis, and testing in the fields of pathology, histology, medical images, and related research and design services; scientific and technological services, namely, providing management, processing and analysis of digital images in the fields of pathology and histology; research and development and consultation related thereto in the field of pathology, histology, and medical imaging; research and development and consultation related thereto in the field of medicine for the diagnosis of clinical pathologies; research and development and consultation related thereto in the field of digital assays; medical and scientific research services for others in the fields of pathology, histology, immunohistochemistry, immunofluorescence, in situ-hybridization, and medical imaging; medical and scientific research services for others, namely, research and design in the field of testing, analyzing and examining biological tissue samples and medical tissue samples; research in the field of artificial intelligence |
International Class | 009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus. |
US Class Codes | 021, 023, 026, 036, 038 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, June 7, 2022 |
Primary Code | 009 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, June 7, 2022 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, June 7, 2022 |
Primary Code | 044 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Reveal Biosciences, Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | San Diego, CA 92121 |
Event Date | Event Description |
Wednesday, December 13, 2023 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
Wednesday, December 13, 2023 | LETTER OF SUSPENSION E-MAILED |
Wednesday, December 13, 2023 | SUSPENSION LETTER WRITTEN |
Wednesday, October 11, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Tuesday, October 10, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Tuesday, October 10, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Thursday, July 6, 2023 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
Thursday, July 6, 2023 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
Tuesday, April 11, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Tuesday, April 11, 2023 | NON-FINAL ACTION E-MAILED |
Tuesday, April 11, 2023 | NON-FINAL ACTION WRITTEN |
Tuesday, April 11, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Tuesday, April 11, 2023 | NON-FINAL ACTION E-MAILED |
Tuesday, April 11, 2023 | NON-FINAL ACTION WRITTEN |
Tuesday, March 14, 2023 | ASSIGNED TO EXAMINER |
Tuesday, June 7, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Tuesday, May 31, 2022 | NEW APPLICATION ENTERED |